Tower Research Capital LLC (TRC) - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 82 filers reported holding STOKE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.22 and the average weighting 1.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$54,283
+51.1%
4,018
+51.0%
0.00%0.0%
Q1 2024$35,924
+35.5%
2,661
-47.2%
0.00%
Q4 2023$26,505
+79.8%
5,039
+34.7%
0.00%
Q3 2023$14,739
-70.4%
3,741
-20.1%
0.00%
-100.0%
Q2 2023$49,780
+138177.8%
4,683
+9.1%
0.00%
+100.0%
Q1 2023$36
-88.7%
4,293
-87.6%
0.00%
-92.3%
Q4 2022$319
-99.3%
34,493
+914.8%
0.01%
+1200.0%
Q3 2022$44,000
-30.2%
3,399
-28.8%
0.00%0.0%
Q2 2022$63,000
-66.8%
4,775
-47.3%
0.00%
-50.0%
Q1 2022$190,000
+153.3%
9,060
+189.0%
0.00%
+100.0%
Q4 2021$75,000
+87.5%
3,135
+100.2%
0.00%0.0%
Q3 2021$40,000
-84.3%
1,566
-79.2%
0.00%
-85.7%
Q2 2021$254,000
+323.3%
7,535
+385.2%
0.01%
+600.0%
Q1 2021$60,000
-51.6%
1,553
-22.3%
0.00%
-75.0%
Q4 2020$124,000
-49.0%
1,999
-72.4%
0.00%
+33.3%
Q3 2020$243,000
+117.0%
7,231
+53.7%
0.00%
-40.0%
Q2 2020$112,0004,7040.01%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$475,340,00079.82%
RTW INVESTMENTS, LP 3,544,248$100,373,0003.79%
Cormorant Asset Management, LP 1,788,643$50,654,0002.02%
RA Capital Management 1,119,963$31,717,0000.96%
Redmile Group, LLC 1,020,778$28,908,0000.69%
SPHERA FUNDS MANAGEMENT LTD. 256,380$7,261,0000.60%
GILDER GAGNON HOWE & CO LLC 1,826,890$51,738,0000.54%
Perceptive Advisors 671,978$19,030,0000.38%
Casdin Capital, LLC 130,000$3,682,0000.34%
Granite Point Capital Management, L.P. 13,200$374,0000.06%
View complete list of STOKE THERAPEUTICS INC shareholders